Chung I K, Ham J S, Kim H S, Park S H, Lee M H, Kim S J
Division of Gastroenterology, Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Choongnam, Republic of Korea.
Gastrointest Endosc. 1999 Jan;49(1):13-8. doi: 10.1016/s0016-5107(99)70439-6.
The endoscopic hemoclip method is a safe and effective hemostatic method for managing bleeding peptic ulcers. We compared the hemostatic efficacy of the endoscopic hemoclip method with that of hypertonic saline-epinephrine (HSE) injection and a combined method in the management of bleeding peptic ulcers.
From July 1994 to July 1997, we conducted a randomized clinical trial of endoscopic hemostasis involving 124 patients with actively bleeding or visible vessels at endoscopic inspection.
Patients were randomly assigned to hemoclip (41 patients), HSE (41 patients), and combined treatment groups (42 patients). Initial hemostasis was achieved in 97.6%, 95.1%, and 97.6% of cases, respectively. Recurrent bleeding developed in 2.4%, 14.6%, and 9.5% of cases. Emergency operations were performed in 4.9%, 14.6%, and 2.3% of cases. The hemostasis rate was 71.4%, 50%, and 66.7% for spurting hemorrhage in each group. Permanent hemostasis was achieved in 95.1%, 85.4%, and 95.2% of cases. Three patients had complications, all in the HSE group.
The hemoclip method is an effective hemostatic procedure and is safer than HSE injection. The combined method does not provide substantial advantage over use of the hemoclip method alone in the hemostatic management of bleeding peptic ulcers.
内镜下止血夹法是治疗消化性溃疡出血的一种安全有效的止血方法。我们比较了内镜下止血夹法与高渗盐水-肾上腺素(HSE)注射法及联合治疗法在治疗消化性溃疡出血中的止血效果。
1994年7月至1997年7月,我们对124例内镜检查时有活动性出血或可见血管的患者进行了内镜止血的随机临床试验。
患者被随机分为止血夹组(41例)、HSE组(41例)和联合治疗组(42例)。初始止血成功率分别为97.6%、95.1%和97.6%。再出血发生率分别为2.4%、14.6%和9.5%。急诊手术率分别为4.9%、14.6%和2.3%。各组中喷射性出血的止血率分别为71.4%、50%和66.7%。永久性止血成功率分别为95.1%、85.4%和95.2%。3例患者出现并发症,均在HSE组。
止血夹法是一种有效的止血方法,且比HSE注射法更安全。在消化性溃疡出血的止血治疗中,联合治疗法相较于单独使用止血夹法并无显著优势。